Page last updated: 2024-09-03

pramipexole and methamphetamine

pramipexole has been researched along with methamphetamine in 3 studies

Compound Research Comparison

Studies (pramipexole)	Trials (pramipexole)	Recent Studies (post-2010) (pramipexole)	Studies (methamphetamine)	Trials (methamphetamine)	Recent Studies (post-2010) (methamphetamine)
1,103	219	517	10,914	409	4,888

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Althaus, JS; Andrus, PK; Hall, ED; Oostveen, JA; VonVoigtlander, PF	1
Napier, TC; Riddle, JL; Rokosik, SL	1

Reviews

1 review(s) available for pramipexole and methamphetamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for pramipexole and methamphetamine

Article	Year
Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain research, 1996, Dec-02, Volume: 742, Issue:1-2 Topics: Animals; Benzothiazoles; Brain Ischemia; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Gerbillinae; Male; Methamphetamine; Nerve Degeneration; Pramipexole; Substantia Nigra; Thiazoles	1996
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls. Behavioural brain research, 2012, Jul-15, Volume: 233, Issue:1 Topics: Adrenergic Agents; Analysis of Variance; Animals; Association Learning; Benzothiazoles; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Forelimb; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reward; Tyrosine 3-Monooxygenase	2012

Article

Year

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

Brain research, 1996, Dec-02, Volume: 742, Issue:1-2

Topics: Animals; Benzothiazoles; Brain Ischemia; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Gerbillinae; Male; Methamphetamine; Nerve Degeneration; Pramipexole; Substantia Nigra; Thiazoles

1996

Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.

Behavioural brain research, 2012, Jul-15, Volume: 233, Issue:1

Topics: Adrenergic Agents; Analysis of Variance; Animals; Association Learning; Benzothiazoles; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Forelimb; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reward; Tyrosine 3-Monooxygenase

2012